PL353064A1 - Nowe chalkony - Google Patents

Nowe chalkony

Info

Publication number
PL353064A1
PL353064A1 PL00353064A PL35306400A PL353064A1 PL 353064 A1 PL353064 A1 PL 353064A1 PL 00353064 A PL00353064 A PL 00353064A PL 35306400 A PL35306400 A PL 35306400A PL 353064 A1 PL353064 A1 PL 353064A1
Authority
PL
Poland
Prior art keywords
medicament
prevention
manufacture
useful
treatment
Prior art date
Application number
PL00353064A
Other languages
English (en)
Inventor
Ezio Bombardelli
Piero Valenti
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of PL353064A1 publication Critical patent/PL353064A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL00353064A 1999-09-03 2000-08-28 Nowe chalkony PL353064A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920910.8A GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones
PCT/EP2000/008366 WO2001017988A1 (en) 1999-09-03 2000-08-28 Novel chalcones

Publications (1)

Publication Number Publication Date
PL353064A1 true PL353064A1 (pl) 2003-10-06

Family

ID=10860346

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353064A PL353064A1 (pl) 1999-09-03 2000-08-28 Nowe chalkony

Country Status (21)

Country Link
US (1) US6620842B2 (pl)
EP (1) EP1212315B1 (pl)
JP (1) JP2003508527A (pl)
KR (1) KR100819576B1 (pl)
CN (1) CN1177843C (pl)
AT (1) ATE235483T1 (pl)
AU (1) AU776226B2 (pl)
CA (1) CA2382130A1 (pl)
CZ (1) CZ2002787A3 (pl)
DE (1) DE60001851T2 (pl)
DK (1) DK1212315T3 (pl)
ES (1) ES2193106T3 (pl)
GB (1) GB9920910D0 (pl)
HK (1) HK1043999B (pl)
HU (1) HUP0202579A3 (pl)
NO (1) NO20021049L (pl)
PL (1) PL353064A1 (pl)
PT (1) PT1212315E (pl)
RU (1) RU2252938C2 (pl)
SK (1) SK3112002A3 (pl)
WO (1) WO2001017988A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003088903A2 (en) 2002-04-17 2003-10-30 Cytokinetics, Inc. Compounds, compositions, and methods
US7638554B2 (en) * 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
DE60326248D1 (de) 2002-07-17 2009-04-02 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
US6864264B1 (en) 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
WO2013127361A1 (en) * 2012-03-01 2013-09-06 The Hong Kong Polytechnic University Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04502322A (ja) * 1988-12-21 1992-04-23 ジ・アップジョン・カンパニー 抗アテローム性動脈硬化症性および抗血栓性１―ベンゾピラン―４―オン類および２―アミノ―１，３―ベンゾオキサジン―４―オン類
US5023341A (en) * 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
JPH05509078A (ja) * 1990-05-17 1993-12-16 ベイラー カレッジ オブ メディシン 成長抑制因とガンおよび細胞増殖性疾患措置法
IT1271301B (it) * 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders

Also Published As

Publication number Publication date
ATE235483T1 (de) 2003-04-15
AU7510900A (en) 2001-04-10
DE60001851D1 (de) 2003-04-30
ES2193106T3 (es) 2003-11-01
AU776226B2 (en) 2004-09-02
HUP0202579A2 (hu) 2002-11-28
JP2003508527A (ja) 2003-03-04
EP1212315B1 (en) 2003-03-26
NO20021049L (no) 2002-05-03
CN1371372A (zh) 2002-09-25
US20030055056A1 (en) 2003-03-20
DK1212315T3 (da) 2003-06-23
PT1212315E (pt) 2003-08-29
SK3112002A3 (en) 2003-10-07
NO20021049D0 (no) 2002-03-01
WO2001017988A1 (en) 2001-03-15
GB9920910D0 (en) 1999-11-10
HUP0202579A3 (en) 2003-07-28
RU2252938C2 (ru) 2005-05-27
US6620842B2 (en) 2003-09-16
KR20020031598A (ko) 2002-05-02
CZ2002787A3 (cs) 2002-06-12
EP1212315A1 (en) 2002-06-12
HK1043999A1 (en) 2002-10-04
CN1177843C (zh) 2004-12-01
DE60001851T2 (de) 2003-12-11
HK1043999B (en) 2003-08-15
KR100819576B1 (ko) 2008-04-22
CA2382130A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
DE60038038D1 (en) Phosphonatverbindungen
IL188250A0 (en) Dosage unit for inhibiting ovulation comprising drospirenone and a complex between ethinyl estradiol and cyclodextrine
PL367682A1 (pl) Pochodne dolastatyny 10
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
NZ508877A (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-L-carnitine and genistein
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
BG105270A (en) Tetrahydropyridoethers
BG105161A (en) Benzocycloheptenes, methods for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
AP2000001898A0 (en) Vitronectin receptor antagonists
PL337361A1 (en) Chalkones of antiproliferative activity
GB9920910D0 (en) Novel chalcones
CA2384433A1 (en) Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
EP0838461A3 (en) Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity
WO2003030884A3 (en) Use of solasonine for the treatment of skin tumors
BG106428A (en) Pharmaceutical compositions for treating psoriasis
IL150082A (en) Unsaturated 14,15 - cyclopropane
ITBO990597A0 (it) Ortesi ortopedica per il trattamento di epicondiliti .
ES1039452U (es) Placa de osteotomia triple de cadera mejorada.
GR990200198U (en) Corset for protecting pelvis region from fractures
ZA200004651B (en) Xylitol compositions for treating upper respiratory conditions.

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed